Drug Trial Radar · NCT00332189
Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006
Last checked: Nov 20, 2026Latest source record: Nov 16, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
111
Actual
Start
Jul 2006
Primary completion
Aug 2009
Study completion Aug 2009
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Jun 1, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 4 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the safety of long-term treatment with Phenoptin in subjects with phenylketonuria (PKU) who participated in Phase 3 clinical studies with Phenoptin.
Conditions
- Phenylketonuria
Interventions
sapropterin dihydrochlorideDrug
5-20mg/kg/day orally, dose may be adjusted up or down as needed at the discretion of the investigator in increments of 5mg/kg/day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Tabulation of the Incidence and Frequency of All AEs and SAEs That Occur Throughout the Study.Time frame: Baseline through Final Visit (a Maximum of 30 months) with AEs collected at month 3 and 6 then at 6 month intervals
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Los Angeles, California
Site not named
Sacramento, California
Site not named
San Jose, California
Site not named
New Haven, Connecticut
Site not named
Atlanta, Georgia
Site not named
Chicago, Illinois
Site not named
Minneapolis, Minnesota
Site not named
St Louis, Missouri
Site not named
New York, New York
Site not named
Portland, Oregon
Site not named
Dallas, Texas
Site not named
Salt Lake City, Utah
Site not named
Seattle, Washington
Site not named
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.